Apellis Pharmaceuticals, Inc. (APLS)
USD 18.53
(-7.21%)
USD 18.53
(-7.21%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -495.21 Million USD | 11.82% |
| 2022 | -617.39 Million USD | -9.66% |
| 2021 | -731.26 Million USD | -154.51% |
| 2020 | -312.23 Million USD | 25.96% |
| 2019 | -298.82 Million USD | -126.14% |
| 2018 | - USD | -147.18% |
| 2017 | -50.89 Million USD | -85.47% |
| 2016 | 157.71 Thousand USD | -526.36% |
| 2015 | 6.39 Million USD | 156.69% |
| 2014 | -11.28 Million USD | -180.56% |
| 2013 | -4.02 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -61.64 Million USD | 25.76% |
| 2024 Q2 | -28.99 Million USD | 52.87% |
| 2024 Q3 | -67.53 Million USD | -58.15% |
| 2023 Q4 | -84.02 Million USD | 43.34% |
| 2023 FY | - USD | 11.82% |
| 2023 Q2 | -114.5 Million USD | 32.47% |
| 2023 Q3 | -148.29 Million USD | -29.51% |
| 2023 Q1 | -169.56 Million USD | -6.45% |
| 2022 Q3 | -149.67 Million USD | -2.03% |
| 2022 FY | - USD | -9.66% |
| 2022 Q2 | -146.7 Million USD | -13.87% |
| 2022 Q1 | -128.82 Million USD | -44.76% |
| 2022 Q4 | -159.29 Million USD | -6.43% |
| 2021 Q4 | -88.99 Million USD | 30.31% |
| 2021 Q1 | -122.51 Million USD | -194.34% |
| 2021 Q2 | -193.79 Million USD | -58.18% |
| 2021 Q3 | -127.69 Million USD | 34.11% |
| 2021 FY | - USD | -154.51% |
| 2020 FY | - USD | 25.96% |
| 2020 Q3 | -128.58 Million USD | -12.44% |
| 2020 Q2 | -114.35 Million USD | -18.68% |
| 2020 Q1 | -96.35 Million USD | 7.84% |
| 2020 Q4 | 129.86 Million USD | 201.0% |
| 2019 Q3 | -68.52 Million USD | -11.05% |
| 2019 Q2 | -61.7 Million USD | -28.75% |
| 2019 FY | - USD | -126.14% |
| 2019 Q1 | -47.92 Million USD | -37.82% |
| 2019 Q4 | -104.55 Million USD | -52.58% |
| 2018 FY | - USD | -147.18% |
| 2018 Q4 | -34.77 Million USD | 1.71% |
| 2018 Q3 | -35.37 Million USD | -5.65% |
| 2018 Q2 | -33.48 Million USD | -57.73% |
| 2018 Q1 | -21.22 Million USD | -17.99% |
| 2017 Q2 | -12.13 Million USD | -34.02% |
| 2017 FY | - USD | -85.47% |
| 2017 Q4 | -17.99 Million USD | -55.25% |
| 2017 Q3 | -11.58 Million USD | 4.48% |
| 2017 Q1 | -9.05 Million USD | -35.54% |
| 2016 Q3 | -7.23 Million USD | -19302.62% |
| 2016 Q4 | -6.67 Million USD | 7.68% |
| 2016 FY | - USD | -526.36% |
| 2016 Q2 | 37.67 Thousand USD | -0.0% |
| 2016 Q1 | 37.67 Thousand USD | 100.54% |
| 2015 Q2 | -3.97 Million USD | 0.0% |
| 2015 Q4 | -6.96 Million USD | -35.02% |
| 2015 Q3 | -5.15 Million USD | -29.64% |
| 2015 Q1 | -3.97 Million USD | -36.52% |
| 2015 FY | - USD | 156.69% |
| 2014 Q3 | -2.66 Million USD | 6.52% |
| 2014 Q2 | -2.85 Million USD | 0.0% |
| 2014 Q4 | -2.91 Million USD | -9.28% |
| 2014 FY | - USD | -180.56% |
| 2014 Q1 | -2.85 Million USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| AbCellera Biologics Inc. | -192.15 Million USD | -157.71% |
| Alkermes plc | 495.04 Million USD | 200.033% |
| Agenus Inc. | -145.92 Million USD | -239.362% |
| Aptorum Group Limited | -9.59 Million USD | -5058.987% |
| Ardelyx, Inc. | -55.35 Million USD | -794.626% |
| Dyadic International, Inc. | -8.22 Million USD | -5917.335% |
| Eton Pharmaceuticals, Inc. | -291 Thousand USD | -170075.601% |
| Lantern Pharma Inc. | -15.78 Million USD | -3036.89% |
| Inhibikase Therapeutics, Inc. | -19.91 Million USD | -2386.949% |
| Novavax, Inc. | -487.39 Million USD | -1.605% |
| Janux Therapeutics, Inc. | -71.02 Million USD | -597.245% |
| Pyxis Oncology, Inc. | -78.49 Million USD | -530.898% |
| TransCode Therapeutics, Inc. | -17.97 Million USD | -2655.236% |
| Ocuphire Pharma, Inc. | -9.96 Million USD | -4868.008% |
| Outlook Therapeutics, Inc. | -57.37 Million USD | -763.099% |
| Madrigal Pharmaceuticals, Inc. | -379.96 Million USD | -30.329% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | -1953.803% |
| SELLAS Life Sciences Group, Inc. | 529 Thousand USD | 93712.665% |
| Syros Pharmaceuticals, Inc. | -157.19 Million USD | -215.03% |
| Barinthus Biotherapeutics plc | -74.81 Million USD | -561.915% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | -2356.526% |
| Xeris Biopharma Holdings, Inc. | -23.73 Million USD | -1986.417% |
| Clearside Biomedical, Inc. | -23.05 Million USD | -2047.675% |
| C4 Therapeutics, Inc. | -122.1 Million USD | -305.568% |
| Alnylam Pharmaceuticals, Inc. | -258.24 Million USD | -91.762% |
| AlloVir, Inc. | -190.14 Million USD | -160.437% |
| Arrowhead Pharmaceuticals, Inc. | -175.67 Million USD | -181.895% |
| VYNE Therapeutics Inc. | -29.25 Million USD | -1592.566% |
| Bicycle Therapeutics plc | -183.4 Million USD | -170.017% |
| BioXcel Therapeutics, Inc. | -165.42 Million USD | -199.364% |
| ChromaDex Corporation | -3.89 Million USD | -12617.283% |
| Chimerix, Inc. | -92.97 Million USD | -432.634% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.43 Million USD | -1014.419% |
| Caribou Biosciences, Inc. | -112.53 Million USD | -340.055% |
| CRISPR Therapeutics AG | -202.7 Million USD | -144.306% |
| Precision BioSciences, Inc. | -32.04 Million USD | -1445.506% |
| Fate Therapeutics, Inc. | -172.22 Million USD | -187.531% |
| Fortress Biotech, Inc. | -133.64 Million USD | -270.548% |
| Fortress Biotech, Inc. | -133.64 Million USD | -270.548% |
| HOOKIPA Pharma Inc. | -77.34 Million USD | -540.279% |
| ImmuCell Corporation | -2.5 Million USD | -19676.189% |
| IDEAYA Biosciences, Inc. | -130.42 Million USD | -279.702% |
| Immix Biopharma, Inc. | -16.13 Million USD | -2969.05% |
| Incyte Corporation | 919.42 Million USD | 153.861% |
| Innoviva, Inc. | 248.96 Million USD | 298.912% |
| IO Biotech, Inc. | -91.22 Million USD | -442.828% |
| Jaguar Health, Inc. | -33.13 Million USD | -1394.706% |
| Keros Therapeutics, Inc. | -152.17 Million USD | -225.418% |
| Ligand Pharmaceuticals Incorporated | 101.72 Million USD | 586.804% |
| ContextLogic Inc. | -324 Million USD | -52.843% |
| MiMedx Group, Inc. | 40.51 Million USD | 1322.23% |
| MEI Pharma, Inc. | 26.38 Million USD | 1977.221% |
| NextCure, Inc. | -59.03 Million USD | -738.786% |
| Onconetix, Inc. | -36.7 Million USD | -1249.102% |
| Oncternal Therapeutics, Inc. | 2.23 Million USD | 22257.092% |
| Opthea Limited | -200.01 Million USD | -147.582% |
| Psyence Biomedical Ltd. | -2.75 Million USD | -17897.332% |
| Vaxcyte, Inc. | -464.88 Million USD | -6.523% |
| PDS Biotechnology Corporation | -40.08 Million USD | -1135.403% |
| Precigen, Inc. | -89.22 Million USD | -455.008% |
| Pharming Group N.V. | 9.87 Million USD | 5113.779% |
| Phathom Pharmaceuticals, Inc. | -159.04 Million USD | -211.358% |
| Pieris Pharmaceuticals, Inc. | -22.76 Million USD | -2075.604% |
| PureTech Health plc | -11.62 Million USD | -4159.147% |
| Rigel Pharmaceuticals, Inc. | -16.98 Million USD | -2816.265% |
| Avidity Biosciences, Inc. | -233.49 Million USD | -112.085% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | -1953.803% |
| Sangamo Therapeutics, Inc. | -87.42 Million USD | -466.428% |
| Sol-Gel Technologies Ltd. | -28.96 Million USD | -1609.806% |
| Acelyrin, Inc. | -381.52 Million USD | -29.797% |
| Salarius Pharmaceuticals, Inc. | -12.88 Thousand USD | -3843246.742% |
| Summit Therapeutics Inc. | 1 Million USD | 49571.628% |
| Sensei Biotherapeutics, Inc. | -33.38 Million USD | -1383.289% |
| Senti Biosciences, Inc. | -61.33 Million USD | -707.374% |
| Stoke Therapeutics, Inc. | -112.3 Million USD | -340.956% |
| Elevation Oncology, Inc. | -41.46 Million USD | -1094.229% |
| Alaunos Therapeutics, Inc. | -30.9 Million USD | -1502.417% |
| Telomir Pharmaceuticals, Inc. Common Stock | -6.11 Million USD | -7996.252% |
| Entrada Therapeutics, Inc. | -321 Thousand USD | -154171.34% |
| VistaGen Therapeutics, Inc. | -32.45 Million USD | -1425.933% |
| Kintara Therapeutics, Inc. | -8.39 Million USD | -5798.178% |
| Wave Life Sciences Ltd. | -58.79 Million USD | -742.339% |
| Seer, Inc. | -97.88 Million USD | -405.911% |
| Verrica Pharmaceuticals Inc. | -62.19 Million USD | -696.198% |
| Aadi Bioscience, Inc. | -65.36 Million USD | -657.609% |
| ESSA Pharma Inc. | -26.45 Million USD | -1771.878% |
| GlycoMimetics, Inc. | -39.12 Million USD | -1165.812% |
| GT Biopharma, Inc. | 5.97 Million USD | 8382.505% |
| Inhibrx Biosciences, Inc. | -206.69 Million USD | -139.588% |
| Akebia Therapeutics, Inc. | -6.86 Million USD | -7110.411% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | 670.441% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | -772.557% |
| Orchestra BioMed Holdings, Inc. | -51.21 Million USD | -866.85% |
| Alzamend Neuro, Inc. | -9.88 Million USD | -4908.757% |
| Sorrento Therapeutics, Inc. | -539.92 Million USD | 8.282% |
| TRACON Pharmaceuticals, Inc. | -6.88 Million USD | -7093.652% |
| Viracta Therapeutics, Inc. | -46.86 Million USD | -956.743% |
| Rocket Pharmaceuticals, Inc. | -236.62 Million USD | -109.284% |
| Aptose Biosciences Inc. | -52.26 Million USD | -847.446% |
| ZyVersa Therapeutics, Inc. | -107.74 Million USD | -359.621% |
| Soligenix, Inc. | -7.85 Million USD | -6206.131% |
| Century Therapeutics, Inc. | -121.2 Million USD | -308.563% |
| Kura Oncology, Inc. | -164.95 Million USD | -200.21% |
| TScan Therapeutics, Inc. | -80.09 Million USD | -518.256% |
| Intensity Therapeutics, Inc. | -10.08 Million USD | -4809.885% |
| Ocean Biomedical, Inc. | -957.73 Thousand USD | -51606.258% |
| CytomX Therapeutics, Inc. | -4.3 Million USD | -11392.481% |
| Autolus Therapeutics plc | -156.77 Million USD | -215.884% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | -484.962% |
| EyePoint Pharmaceuticals, Inc. | -69 Million USD | -617.687% |
| Eterna Therapeutics Inc. | -19.93 Million USD | -2384.253% |
| Adaptive Biotechnologies Corporation | -189.27 Million USD | -161.638% |
| GRI Bio, Inc. | -10.89 Million USD | -4444.054% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | -10866.392% |
| Tenaya Therapeutics, Inc. | -122.5 Million USD | -304.234% |
| IGM Biosciences, Inc. | -253.35 Million USD | -95.459% |
| INmune Bio, Inc. | - USD | Infinity% |
| Heron Therapeutics, Inc. | -103.79 Million USD | -377.119% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | -1198.634% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | -3130.148% |
| Entero Therapeutics, Inc. | -15.74 Million USD | -3045.547% |
| Milestone Pharmaceuticals Inc. | -56.84 Million USD | -771.16% |
| X4 Pharmaceuticals, Inc. | -107.1 Million USD | -362.369% |
| Atara Biotherapeutics, Inc. | -265.99 Million USD | -86.172% |
| Coherus BioSciences, Inc. | -193.93 Million USD | -155.344% |
| Verastem, Inc. | -83.16 Million USD | -495.449% |
| Abeona Therapeutics Inc. | -50.57 Million USD | -879.22% |
| Pliant Therapeutics, Inc. | -158.22 Million USD | -212.973% |
| Tonix Pharmaceuticals Holding Corp. | -114.08 Million USD | -334.057% |
| Histogen Inc. | -10.5 Million USD | -4614.948% |
| Aprea Therapeutics, Inc. | -14.27 Million USD | -3367.935% |
| Surrozen, Inc. | -41.13 Million USD | -1103.985% |
| Organovo Holdings, Inc. | -14.8 Million USD | -3244.664% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | 15441665.326% |
| Ovid Therapeutics Inc. | -58.71 Million USD | -743.441% |
| Panbela Therapeutics, Inc. | -51.29 Million USD | -865.437% |
| CASI Pharmaceuticals, Inc. | -21.53 Million USD | -2199.136% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.33 Million USD | -5839.202% |
| Centessa Pharmaceuticals plc | -166.06 Million USD | -198.201% |
| Hepion Pharmaceuticals, Inc. | -49.25 Million USD | -905.332% |
| Arcturus Therapeutics Holdings Inc. | -24.16 Million USD | -1949.205% |
| BioRestorative Therapies, Inc. | -15.05 Million USD | -3189.337% |
| Apollomics, Inc. | -171.74 Million USD | -188.337% |
| Amarin Corporation plc | -50.9 Million USD | -872.88% |
| Mesoblast Limited | -61.33 Million USD | -707.44% |
| Turnstone Biologics Corp. | -56.23 Million USD | -780.626% |
| Kymera Therapeutics, Inc. | -143.2 Million USD | -245.815% |
| Synaptogenix, Inc. | -8.3 Million USD | -5861.006% |
| Tiziana Life Sciences Ltd | -15.33 Million USD | -3128.444% |
| Aurinia Pharmaceuticals Inc. | -63.04 Million USD | -685.463% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -10235.271% |
| Monopar Therapeutics Inc. | 429.03 Thousand USD | 115523.307% |
| Exelixis, Inc. | 196.6 Million USD | 351.885% |
| Better Therapeutics, Inc. | -38.26 Million USD | -1194.263% |
| Nurix Therapeutics, Inc. | -141.4 Million USD | -250.198% |
| NLS Pharmaceutics AG | -11.79 Million USD | -4098.249% |
| Dermata Therapeutics, Inc. | 247.21 Thousand USD | 200415.109% |
| Aridis Pharmaceuticals, Inc. | -29.5 Million USD | -1578.34% |
| Gritstone bio, Inc. | -126.86 Million USD | -290.351% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | -662.039% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -12280.442% |
| Avid Bioservices, Inc. | -11.48 Million USD | -4213.309% |
| Insmed Incorporated | -654.73 Million USD | 24.365% |
| Virpax Pharmaceuticals, Inc. | -2.24 Million USD | -21912.127% |
| MediWound Ltd. | -4.89 Million USD | -10020.805% |
| OmniAb, Inc. | -49.73 Million USD | -895.779% |
| Alector, Inc. | -142.89 Million USD | -246.563% |
| Seres Therapeutics, Inc. | -85.43 Million USD | -479.642% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | -849.626% |
| Zai Lab Limited | -366.57 Million USD | -35.092% |
| Revance Therapeutics, Inc. | -290.63 Million USD | -70.388% |
| Aura Biosciences, Inc. | -83.69 Million USD | -491.678% |
| Lyell Immunopharma, Inc. | -225.24 Million USD | -119.85% |
| Immunic, Inc. | -99.11 Million USD | -399.648% |
| Tarsus Pharmaceuticals, Inc. | -131.67 Million USD | -276.1% |
| Veracyte, Inc. | -49.4 Million USD | -902.269% |
| InMed Pharmaceuticals Inc. | -7.06 Million USD | -6910.417% |
| FibroGen, Inc. | -261.4 Million USD | -89.442% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | -4344.942% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -6973.101% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.71 Million USD | -2545.801% |
| Jazz Pharmaceuticals plc | 1.44 Billion USD | 134.166% |
| Cyclacel Pharmaceuticals, Inc. | -25.42 Million USD | -1847.962% |
| Amylyx Pharmaceuticals, Inc. | 39.89 Million USD | 1341.441% |
| TG Therapeutics, Inc. | 26.1 Million USD | 1997.36% |
| Galecto, Inc. | -37.51 Million USD | -1219.894% |
| Calithera Biosciences, Inc. | -38.26 Million USD | -1194.162% |
| Fortrea Holdings Inc. | 167.3 Million USD | 396.002% |
| KalVista Pharmaceuticals, Inc. | -134.28 Million USD | -268.79% |
| Aptevo Therapeutics Inc. | -28.31 Million USD | -1649.182% |
| XBiotech Inc. | -35.76 Million USD | -1284.586% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | -662.039% |
| Lyra Therapeutics, Inc. | -65.25 Million USD | -658.944% |
| Foghorn Therapeutics Inc. | -104.45 Million USD | -374.09% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | -1828.993% |
| Theravance Biopharma, Inc. | -40.86 Million USD | -1111.763% |
| Ultragenyx Pharmaceutical Inc. | -516.45 Million USD | 4.113% |
| Metagenomi, Inc. Common Stock | -56.02 Million USD | -783.974% |
| Vaxxinity, Inc. | -56.05 Thousand USD | -883400.74% |
| BioCryst Pharmaceuticals, Inc. | -116.33 Million USD | -325.677% |
| Gain Therapeutics, Inc. | -22.16 Million USD | -2133.744% |
| Cartesian Therapeutics, Inc. | -235.06 Million USD | -110.671% |
| NexImmune, Inc. | -28.16 Million USD | -1658.093% |
| Creative Medical Technology Holdings, Inc. | -5.52 Million USD | -8862.206% |
| Marker Therapeutics, Inc. | -11.79 Million USD | -4099.454% |
| Regeneron Pharmaceuticals, Inc. | 4.65 Billion USD | 110.64% |
| Chemomab Therapeutics Ltd. | -25.39 Million USD | -1850.264% |
| Scopus BioPharma Inc. | -11.71 Million USD | -4127.821% |
| RAPT Therapeutics, Inc. | -125.84 Million USD | -293.506% |
| Ainos, Inc. | -8.77 Million USD | -5544.654% |
| Pluri Inc. | -20.22 Million USD | -2348.509% |
| Prothena Corporation plc | -190.1 Million USD | -160.489% |
| Adaptimmune Therapeutics plc | -128.19 Million USD | -286.286% |
| Celularity Inc. | -183.94 Million USD | -169.215% |
| Rallybio Corporation | -72.37 Million USD | -584.248% |
| Cue Biopharma, Inc. | -46.05 Million USD | -975.33% |
| MeiraGTx Holdings plc | -57.05 Million USD | -767.999% |
| Omeros Corporation | -163.61 Million USD | -202.678% |
| Humacyte, Inc. | -96.45 Million USD | -413.395% |
| Immunocore Holdings plc | -59.64 Million USD | -730.208% |
| Cocrystal Pharma, Inc. | -19.37 Million USD | -2456.324% |
| Cidara Therapeutics, Inc. | -24.36 Million USD | -1932.469% |
| Blueprint Medicines Corporation | -474.61 Million USD | -4.34% |
| CalciMedica, Inc. | -34.18 Million USD | -1348.451% |
| Cabaletta Bio, Inc. | -73.23 Million USD | -576.204% |
| Marinus Pharmaceuticals, Inc. | -125.49 Million USD | -294.6% |
| Scholar Rock Holding Corporation | -168.45 Million USD | -193.979% |
| Sana Biotechnology, Inc. | -252.39 Million USD | -96.209% |
| Pulmatrix, Inc. | -12.64 Million USD | -3815.95% |
| Elicio Therapeutics, Inc. | -32.96 Million USD | -1402.187% |
| Vigil Neuroscience, Inc. | -88.46 Million USD | -459.769% |
| Intellia Therapeutics, Inc. | -506.31 Million USD | 2.193% |
| Adlai Nortye Ltd. American Depositary Shares | -101.21 Million USD | -389.266% |
| Cytokinetics, Incorporated | -456.68 Million USD | -8.436% |
| Eloxx Pharmaceuticals, Inc. | -33.37 Million USD | -1383.867% |
| Nutriband Inc. | -5.12 Million USD | -9568.734% |
| Protara Therapeutics, Inc. | -43.27 Million USD | -1044.414% |
| Vor Biopharma Inc. | -114.37 Million USD | -332.987% |
| Roivant Sciences Ltd. | -996.51 Million USD | 50.306% |
| Evogene Ltd. | -23.2 Million USD | -2034.162% |
| ProKidney Corp. | -147.66 Million USD | -235.352% |
| Applied Therapeutics, Inc. | -64.53 Million USD | -667.353% |
| Hoth Therapeutics, Inc. | -153.14 Thousand USD | -323252.421% |
| BridgeBio Pharma, Inc. | -565.46 Million USD | 12.425% |
| CorMedix Inc. | -48.88 Million USD | -912.97% |
| BioLineRx Ltd. | -57.06 Million USD | -767.862% |
| Tango Therapeutics, Inc. | -111.75 Million USD | -343.11% |
| Galectin Therapeutics Inc. | -202 Thousand USD | -245053.96% |
| Atai Life Sciences N.V. | -36.31 Million USD | -1263.804% |
| Renovaro Biosciences Inc. | -79.51 Million USD | -522.774% |
| Aerovate Therapeutics, Inc. | -81.31 Million USD | -509.018% |
| Zentalis Pharmaceuticals, Inc. | -275.5 Million USD | -79.748% |
| Sagimet Biosciences Inc. | -30.74 Million USD | -1510.966% |
| MediciNova, Inc. | -9.87 Million USD | -4912.272% |
| Praxis Precision Medicines, Inc. | -125.94 Million USD | -293.209% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | -32262.48% |
| GeoVax Labs, Inc. | -26.66 Million USD | -1756.895% |
| Axsome Therapeutics, Inc. | -224.99 Million USD | -120.103% |
| Biomea Fusion, Inc. | -124.62 Million USD | -297.377% |
| PTC Therapeutics, Inc. | -330.34 Million USD | -49.909% |
| Mereo BioPharma Group plc | -26.05 Million USD | -1800.564% |
| Cullinan Oncology, Inc. | -190.33 Million USD | -160.173% |
| Syndax Pharmaceuticals, Inc. | -229.94 Million USD | -115.363% |
| Absci Corporation | -95.45 Million USD | -418.779% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | -1549.329% |
| 4D Molecular Therapeutics, Inc. | -107.11 Million USD | -362.304% |
| Dyne Therapeutics, Inc. | -233.47 Million USD | -112.104% |
| Kiniksa Pharmaceuticals, Ltd. | -22.85 Million USD | -2066.751% |
| Ventyx Biosciences, Inc. | -207.83 Million USD | -138.27% |
| Allakos Inc. | -189.91 Million USD | -160.754% |
| Imunon, Inc. | -19.87 Million USD | -2391.217% |
| Fulcrum Therapeutics, Inc. | -108.49 Million USD | -356.449% |
| Corcept Therapeutics Incorporated | 108.32 Million USD | 557.157% |
| BioAtla, Inc. | -122.24 Million USD | -305.11% |
| NLS Pharmaceutics AG | -11.79 Million USD | -4098.249% |
| Bio-Path Holdings, Inc. | -15.76 Million USD | -3042.002% |
| Allogene Therapeutics, Inc. | -300.29 Million USD | -64.909% |
| Larimar Therapeutics, Inc. | -41.44 Million USD | -1094.805% |
| XOMA Corporation | -39.36 Million USD | -1158.094% |
| Kezar Life Sciences, Inc. | -99.25 Million USD | -398.933% |
| Cara Therapeutics, Inc. | -117.65 Million USD | -320.919% |
| aTyr Pharma, Inc. | -52.17 Million USD | -849.08% |
| Aligos Therapeutics, Inc. | -83.81 Million USD | -490.838% |
| Akero Therapeutics, Inc. | -148.63 Million USD | -233.182% |
| Viridian Therapeutics, Inc. | -234.56 Million USD | -111.119% |
| Eliem Therapeutics, Inc. | -13.65 Million USD | -3527.122% |
| EyeGate Pharmaceuticals, Inc. | -8.04 Million USD | -6057.579% |
| Akari Therapeutics, Plc | -16.8 Million USD | -2847.334% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | 262524.618% |
| Halozyme Therapeutics, Inc. | 451.94 Million USD | 209.573% |
| Lexaria Bioscience Corp. | -6.38 Million USD | -7651.449% |
| UroGen Pharma Ltd. | -63.83 Million USD | -675.816% |
| Sutro Biopharma, Inc. | -67.91 Million USD | -629.163% |
| ZIVO Bioscience, Inc. | -7.26 Million USD | -6718.259% |
| Orgenesis Inc. | -60.71 Million USD | -715.592% |
| Entera Bio Ltd. | -8.8 Million USD | -5524.841% |
| GH Research PLC | -41.15 Million USD | -1103.341% |
| Lisata Therapeutics, Inc. | -25.51 Million USD | -1840.558% |
| Reneo Pharmaceuticals, Inc. | -82.23 Million USD | -502.205% |
| Xencor, Inc. | -125.87 Million USD | -293.418% |
| 60 Degrees Pharmaceuticals, Inc. | -1.42 Million USD | -34614.012% |
| Replimune Group, Inc. | -230.19 Million USD | -115.124% |
| Coeptis Therapeutics Holdings, Inc. | -20.15 Million USD | -2356.694% |
| Vanda Pharmaceuticals Inc. | -10.94 Million USD | -4425.781% |
| Lexaria Bioscience Corp. | -6.38 Million USD | -7651.449% |
| Portage Biotech Inc. | -18.19 Million USD | -2621.089% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | -32262.48% |
| Olema Pharmaceuticals, Inc. | -104.58 Million USD | -373.506% |
| OncoCyte Corporation | -23.12 Million USD | -2041.638% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | -4282.258% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | -4222.405% |
| Purple Biotech Ltd. | -22.22 Million USD | -2128.171% |
| CollPlant Biotechnologies Ltd. | -6.41 Million USD | -7625.601% |
| scPharmaceuticals Inc. | -46.06 Million USD | -975.12% |
| ProMIS Neurosciences, Inc. | -17.8 Million USD | -2680.572% |
| HilleVax, Inc. | -132.46 Million USD | -273.84% |
| NeuroSense Therapeutics Ltd. | -10.63 Million USD | -4557.303% |
| Tharimmune, Inc. | -9.3 Million USD | -5223.368% |
| Genprex, Inc. | -31.06 Million USD | -1494.34% |
| Neumora Therapeutics, Inc. Common Stock | -187.52 Million USD | -164.076% |
| Atossa Therapeutics, Inc. | -31.35 Million USD | -1479.419% |
| XTL Biopharmaceuticals Ltd. | -764 Thousand USD | -64718.194% |
| Virios Therapeutics, Inc. | 150.9 Thousand USD | 328262.938% |
| OKYO Pharma Limited | -15.74 Thousand USD | -3144921.52% |
| Savara Inc. | -59.13 Million USD | -737.453% |
| Curis, Inc. | -45.13 Million USD | -997.08% |
| Daré Bioscience, Inc. | -30.7 Million USD | -1512.985% |
| Carmell Therapeutics Corporation | -15.19 Million USD | -3159.866% |
| Titan Pharmaceuticals, Inc. | -7.16 Million USD | -6811.528% |
| Achieve Life Sciences, Inc. | -26.73 Million USD | -1752.364% |
| BeiGene, Ltd. | -1.12 Billion USD | 55.966% |
| Kiromic BioPharma, Inc. | -16.3 Million USD | -2937.881% |
| Revolution Medicines, Inc. Warrant | -430.58 Million USD | -15.01% |
| Protagonist Therapeutics, Inc. | -90.34 Million USD | -448.164% |
| Erasca, Inc. | -121.31 Million USD | -308.219% |
| bluebird bio, Inc. | -167.16 Million USD | -196.248% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | -10907.732% |
| BioMarin Pharmaceutical Inc. | 310.28 Million USD | 259.599% |
| DBV Technologies S.A. | -85.98 Million USD | -475.947% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | -10907.732% |
| Moderna, Inc. | -3.28 Billion USD | 84.916% |
| Vincerx Pharma, Inc. | -42.6 Million USD | -1062.222% |
| Fresh Tracks Therapeutics, Inc. | -5.64 Million USD | -8667.9% |
| Molecular Templates, Inc. | 1.43 Million USD | 34730.14% |
| Acrivon Therapeutics, Inc. Common Stock | -59.85 Million USD | -727.393% |
| Travere Therapeutics, Inc. | -326.24 Million USD | -51.791% |
| Monte Rosa Therapeutics, Inc. | -137.08 Million USD | -261.233% |
| Spruce Biosciences, Inc. | -47.36 Million USD | -945.499% |
| Celldex Therapeutics, Inc. | -139.03 Million USD | -256.18% |
| Cogent Biosciences, Inc. | -205.86 Million USD | -140.557% |
| MacroGenics, Inc. | 2.01 Million USD | 24651.859% |
| RenovoRx, Inc. | -11.39 Million USD | -4247.77% |
| Adicet Bio, Inc. | -136.53 Million USD | -262.699% |
| Prime Medicine, Inc. | -193.75 Million USD | -155.581% |
| Aditxt, Inc. | -25.45 Million USD | -1845.211% |
| Adagene Inc. | -14.95 Million USD | -3212.274% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -6674.341% |
| Quantum-Si incorporated | -91.8 Million USD | -439.422% |
| Maravai LifeSciences Holdings, Inc. | 712.4 Million USD | 169.512% |
| Acurx Pharmaceuticals, Inc. | - USD | Infinity% |
| Voyager Therapeutics, Inc. | 126.45 Million USD | 491.61% |
| SciSparc Ltd. | -5.28 Million USD | -9275.445% |
| Vericel Corporation | 2.86 Million USD | 17390.887% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | -520035.913% |
| Minerva Neurosciences, Inc. | -21.69 Million USD | -2182.98% |
| Generation Bio Co. | -133.3 Million USD | -271.501% |
| Astria Therapeutics, Inc. | -83.03 Million USD | -496.424% |
| Black Diamond Therapeutics, Inc. | -86.02 Million USD | -475.673% |
| Arcutis Biotherapeutics, Inc. | -227.43 Million USD | -117.738% |
| Invivyd, Inc. | -196.61 Million USD | -151.868% |
| Relay Therapeutics, Inc. | -374.15 Million USD | -32.355% |
| Quoin Pharmaceuticals, Ltd. | -9.27 Million USD | -5239.318% |
| Spero Therapeutics, Inc. | 27.15 Million USD | 1923.713% |
| Artelo Biosciences, Inc. | -10.28 Million USD | -4714.886% |
| 2seventy bio, Inc. | -206.41 Million USD | -139.907% |
| ADMA Biologics, Inc. | 5.12 Million USD | 9772.09% |
| Clene Inc. | -43.24 Million USD | -1045.235% |
| Capricor Therapeutics, Inc. | -23 Million USD | -2052.251% |
| Boundless Bio, Inc. Common Stock | -48.47 Million USD | -921.538% |
| GeoVax Labs, Inc. | -26.66 Million USD | -1756.895% |
| Recursion Pharmaceuticals, Inc. | -299.56 Million USD | -65.309% |
| Citius Pharmaceuticals, Inc. | -36.72 Million USD | -1248.271% |
| Contineum Therapeutics, Inc. Class A Common Stock | 23.57 Million USD | 2200.755% |
| Relmada Therapeutics, Inc. | 4.91 Million USD | 10185.24% |
| Finch Therapeutics Group, Inc. | -32.48 Million USD | -1424.571% |
| ALX Oncology Holdings Inc. | -158.4 Million USD | -212.625% |
| Vir Biotechnology, Inc. | -684.3 Million USD | 27.633% |
| Evaxion Biotech A/S | -21.4 Million USD | -2213.746% |
| Ocular Therapeutix, Inc. | -66.41 Million USD | -645.631% |
| Verve Therapeutics, Inc. | -217.66 Million USD | -127.506% |
| Trevena, Inc. | -35.28 Million USD | -1303.341% |
| Surrozen, Inc. | -41.13 Million USD | -1103.985% |
| Tyra Biosciences, Inc. | -79.59 Million USD | -522.187% |
| Cingulate Inc. | -22.95 Million USD | -2057.591% |
| Galmed Pharmaceuticals Ltd. | -7.46 Million USD | -6537.327% |
| Unity Biotechnology, Inc. | -37.28 Million USD | -1228.249% |
| Tenax Therapeutics, Inc. | -8.22 Million USD | -5919.799% |
| Terns Pharmaceuticals, Inc. | -102.26 Million USD | -384.238% |
| ACADIA Pharmaceuticals Inc. | -67.82 Million USD | -630.109% |
| Connect Biopharma Holdings Limited | -58.37 Million USD | -748.371% |
| Clearmind Medicine Inc. | -8.71 Million USD | -5585.113% |
| Kronos Bio, Inc. | -121.83 Million USD | -306.477% |
| Bolt Biotherapeutics, Inc. | -74.34 Million USD | -566.125% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | -20183.778% |
| Viking Therapeutics, Inc. | -100.82 Million USD | -391.149% |
| Statera Biopharma, Inc. | 38.93 Million USD | 1371.893% |
| ImmunityBio, Inc. | -436.18 Million USD | -13.533% |
| Korro Bio, Inc. | -80.9 Million USD | -512.097% |
| Kineta, Inc. | -15.71 Million USD | -3051.4% |
| BioVie Inc. | -31.95 Million USD | -1449.946% |
| Codexis, Inc. | -49.28 Million USD | -904.831% |
| Celularity Inc. | -183.94 Million USD | -169.215% |
| Crinetics Pharmaceuticals, Inc. | -221.51 Million USD | -123.561% |
| Celcuity Inc. | -58.3 Million USD | -749.273% |
| Virax Biolabs Group Limited | -6.6 Million USD | -7392.816% |
| Cibus, Inc. | -314.58 Million USD | -57.417% |
| Eledon Pharmaceuticals, Inc. | - USD | Infinity% |
| eFFECTOR Therapeutics, Inc. | -33.73 Million USD | -1368.031% |
| IN8bio, Inc. | -28.5 Million USD | -1637.339% |
| Kodiak Sciences Inc. | -259.02 Million USD | -91.184% |
| Annexon, Inc. | -141.57 Million USD | -249.787% |
| Adverum Biotechnologies, Inc. | -112.59 Million USD | -339.801% |
| Assembly Biosciences, Inc. | -64.19 Million USD | -671.405% |
| Avalo Therapeutics, Inc. | -27.95 Million USD | -1671.458% |
| Ionis Pharmaceuticals, Inc. | -230.01 Million USD | -115.3% |
| Eyenovia, Inc. | -24.1 Million USD | -1954.303% |
| Puma Biotechnology, Inc. | 44.78 Million USD | 1205.777% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | -152742.901% |
| Xilio Therapeutics, Inc. | -73.8 Million USD | -570.981% |
| Arcellx, Inc. | -64.14 Million USD | -672.018% |
| Cardiff Oncology, Inc. | -45.01 Million USD | -1000.127% |
| Enanta Pharmaceuticals, Inc. | -123.47 Million USD | -301.059% |
| Regulus Therapeutics Inc. | -30.88 Million USD | -1503.559% |
| Moolec Science SA | -52.07 Million USD | -850.947% |
| Acumen Pharmaceuticals, Inc. | -51.6 Million USD | -859.6% |
| Geron Corporation | -174.78 Million USD | -183.331% |
| LAVA Therapeutics N.V. | -40.41 Million USD | -1125.254% |
| Royalty Pharma plc | 1.88 Billion USD | 126.239% |
| Atea Pharmaceuticals, Inc. | -119.59 Million USD | -314.08% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | -5210.999% |
| TFF Pharmaceuticals, Inc. | -20.74 Million USD | -2287.623% |
| Mersana Therapeutics, Inc. | -166.08 Million USD | -198.176% |
| Humacyte, Inc. | -96.45 Million USD | -413.395% |
| Structure Therapeutics Inc. | -102.45 Million USD | -383.326% |
| 89bio, Inc. | -134.46 Million USD | -268.288% |
| PMV Pharmaceuticals, Inc. | -78.87 Million USD | -527.843% |
| Avenue Therapeutics, Inc. | 4.05 Million USD | 12321.397% |
| Genelux Corporation | -24.16 Million USD | -1949.29% |
| Trevi Therapeutics, Inc. | -33.8 Million USD | -1365.121% |
| Lexicon Pharmaceuticals, Inc. | -163.46 Million USD | -202.948% |
| Notable Labs, Ltd. | -14.4 Million USD | -3338.965% |
| Liquidia Corporation | -70.05 Million USD | -606.929% |
| Mustang Bio, Inc. | -48.06 Million USD | -930.337% |
| Immunovant, Inc. | -269.97 Million USD | -83.426% |
| Quantum-Si incorporated | -91.8 Million USD | -439.422% |
| Arbutus Biopharma Corporation | -70.98 Million USD | -597.618% |
| DiaMedica Therapeutics Inc. | -19.3 Million USD | -2464.797% |
| Vera Therapeutics, Inc. | -102.01 Million USD | -385.444% |
| Acasti Pharma Inc. | -11.3 Million USD | -4282.01% |
| MiNK Therapeutics, Inc. | -22.25 Million USD | -2125.343% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | -3130.148% |
| Xenon Pharmaceuticals Inc. | -210.51 Million USD | -135.24% |
| Elevai Labs, Inc. Common Stock | -4.27 Million USD | -11496.516% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | -3018.457% |
| Tempest Therapeutics, Inc. | -28.77 Million USD | -1620.917% |
| Soleno Therapeutics, Inc. | -37.03 Million USD | -1237.324% |
| PepGen Inc. | -83.58 Million USD | -492.485% |
| Moleculin Biotech, Inc. | -29.5 Million USD | -1578.454% |
| United Therapeutics Corporation | 1.38 Billion USD | 135.709% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -2062.777% |
| Solid Biosciences Inc. | -93.43 Million USD | -430.012% |
| BriaCell Therapeutics Corp. | -4.77 Million USD | -10278.005% |
| Immuneering Corporation | -58.06 Million USD | -752.918% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | 15441665.326% |
| Silo Pharma, Inc. | -3.62 Million USD | -13556.42% |
| Belite Bio, Inc | -31.52 Million USD | -1470.652% |
| XOMA Corporation | -39.36 Million USD | -1158.094% |
| ARS Pharmaceuticals, Inc. | -67.44 Million USD | -634.222% |
| Bionomics Limited | -9.83 Million USD | -4934.169% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -489.642% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | -1330.998% |
| uniQure N.V. | -253.1 Million USD | -95.658% |
| Cassava Sciences, Inc. | -95.68 Million USD | -417.532% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -6674.341% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | -282.391% |
| Forte Biosciences, Inc. | -32.47 Million USD | -1424.805% |
| Anebulo Pharmaceuticals, Inc. | -8.05 Million USD | -6051.328% |
| Enlivex Therapeutics Ltd. | -28.21 Million USD | -1654.885% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | -152742.901% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | -4344.942% |
| FibroBiologics, Inc. Common Stock | -15.9 Million USD | -3014.339% |
| Altimmune, Inc. | -87.93 Million USD | -463.156% |
| Amicus Therapeutics, Inc. | -92.07 Million USD | -437.811% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | -1330.998% |
| Compugen Ltd. | -12.51 Million USD | -3856.624% |
| Peak Bio, Inc. | -1356.23 USD | -36513691.908% |
| Zevra Therapeutics, Inc. | -48.59 Million USD | -918.995% |
| Benitec Biopharma Inc. | -22.49 Million USD | -2101.916% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | -104.377% |
| NKGen Biotech, Inc. Common Stock | -28.54 Million USD | -1634.965% |
| Zura Bio Limited | -60.56 Million USD | -717.679% |
| PolyPid Ltd. | -20.26 Million USD | -2343.917% |
| Aileron Therapeutics, Inc. | -15.61 Million USD | -3071.786% |
| NKGen Biotech, Inc. Warrants | -28.54 Million USD | -1634.965% |
| Instil Bio, Inc. | -146.12 Million USD | -238.902% |
| argenx SE | -216.02 Million USD | -129.24% |
| Immunome, Inc. | -28.27 Million USD | -1651.657% |
| Compass Therapeutics, Inc. | -48.47 Million USD | -921.622% |
| Verona Pharma plc | -52.46 Million USD | -843.842% |
| enGene Holdings Inc. Warrants | -94.77 Million USD | -422.529% |
| Shattuck Labs, Inc. | -87.61 Million USD | -465.213% |
| CervoMed Inc. | -2.17 Million USD | -22701.093% |
| LENZ Therapeutics, Inc. | -122.24 Million USD | -305.1% |
| Plus Therapeutics, Inc. | -12.69 Million USD | -3801.45% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | -927.963% |
| Moolec Science SA | -52.07 Million USD | -850.947% |
| Enveric Biosciences, Inc. | -17.13 Million USD | -2789.215% |
| Inovio Pharmaceuticals, Inc. | -130.39 Million USD | -279.789% |
| AnaptysBio, Inc. | -143.16 Million USD | -245.905% |
| Design Therapeutics, Inc. | -66.32 Million USD | -646.643% |
| Leap Therapeutics, Inc. | -80.98 Million USD | -511.47% |
| NeurAxis, Inc. | -6.66 Million USD | -7330.586% |
| Seelos Therapeutics, Inc. | -37.75 Million USD | -1211.817% |
| Lumos Pharma, Inc. | -36.57 Million USD | -1254.145% |
| Achilles Therapeutics plc | -70.44 Million USD | -603.005% |
| enGene Holdings Inc. Common Stock | -94.77 Million USD | -422.529% |
| 180 Life Sciences Corp. | -22.13 Million USD | -2137.329% |
| Opiant Pharmaceuticals, Inc. | 5.82 Million USD | 8595.282% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | -20183.778% |
| Nutriband Inc. | -5.12 Million USD | -9568.734% |
| ORIC Pharmaceuticals, Inc. | -109.74 Million USD | -351.226% |
| CG Oncology, Inc. Common stock | -55.43 Million USD | -793.367% |
| Fractyl Health, Inc. Common Stock | -50.55 Million USD | -879.646% |
| Rani Therapeutics Holdings, Inc. | -65.27 Million USD | -658.63% |
| MoonLake Immunotherapeutics | -54.1 Million USD | -815.194% |
| Palisade Bio, Inc. | -12.28 Million USD | -3932.335% |
| Tourmaline Bio, Inc. | -45.37 Million USD | -991.35% |
| Beam Therapeutics Inc. | -156.47 Million USD | -216.483% |
| Neurogene Inc. | -52.28 Million USD | -847.12% |
| Mirum Pharmaceuticals, Inc. | -136.49 Million USD | -262.819% |
| AEON Biopharma, Inc. | -48.36 Million USD | -923.988% |
| CARGO Therapeutics, Inc. Common Stock | -93.01 Million USD | -432.382% |
| Sesen Bio, Inc. | -50.84 Million USD | -874.058% |
| Enliven Therapeutics, Inc. | -81.93 Million USD | -504.417% |
| Kiora Pharmaceuticals, Inc. | -12.35 Million USD | -3909.798% |
| Iovance Biotherapeutics, Inc. | -427.43 Million USD | -15.857% |
| Taysha Gene Therapies, Inc. | -105.19 Million USD | -370.746% |
| Athira Pharma, Inc. | -116.7 Million USD | -324.334% |
| Vaccinex, Inc. | -19.74 Million USD | -2407.651% |
| HCW Biologics Inc. | -23.57 Million USD | -2000.483% |
| XOMA Corporation | -39.36 Million USD | -1158.094% |
| Nektar Therapeutics | -243.1 Million USD | -103.701% |
| Arvinas, Inc. | -394.8 Million USD | -25.433% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | 262524.618% |
| Merus N.V. | -149.2 Million USD | -231.895% |
| Omega Therapeutics, Inc. | -93.49 Million USD | -429.694% |
| Quince Therapeutics, Inc. | -31.26 Million USD | -1484.168% |
| Rezolute, Inc. | -68.42 Million USD | -623.749% |
| Clene Inc. | -43.24 Million USD | -1045.235% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -3111.029% |
| BeyondSpring Inc. | -21.54 Million USD | -2199.03% |
| Synlogic, Inc. | -55.16 Million USD | -797.756% |
| Allarity Therapeutics, Inc. | -12.08 Million USD | -3998.411% |
| Phio Pharmaceuticals Corp. | -10.64 Million USD | -4553.364% |
| Peak Bio, Inc. | -1356.23 USD | -36513691.908% |
| Werewolf Therapeutics, Inc. | -32.46 Million USD | -1425.369% |
| Krystal Biotech, Inc. | 17.9 Million USD | 2865.924% |
| Karyopharm Therapeutics Inc. | -118.42 Million USD | -318.171% |
| SpringWorks Therapeutics, Inc. | -341.34 Million USD | -45.076% |
| Lipella Pharmaceuticals Inc. | -4.6 Million USD | -10650.425% |
| MannKind Corporation | 15.12 Million USD | 3373.257% |
| Ikena Oncology, Inc. | -74.39 Million USD | -565.633% |
| Cyclerion Therapeutics, Inc. | -12.59 Million USD | -3832.431% |
| Gyre Therapeutics, Inc. | 20.32 Million USD | 2536.223% |
| Gossamer Bio, Inc. | -172.15 Million USD | -187.659% |
| CohBar, Inc. | -12.06 Million USD | -4004.267% |
| Cognition Therapeutics, Inc. | -25.5 Million USD | -1841.319% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | -1549.329% |
| Legend Biotech Corporation | -477.87 Million USD | -3.628% |
| Mural Oncology plc | -192.72 Million USD | -156.959% |
| Biora Therapeutics, Inc. | -114.05 Million USD | -334.19% |
| PaxMedica, Inc. Common Stock | -16.14 Million USD | -2967.22% |
| Disc Medicine, Inc. | -91.02 Million USD | -444.038% |
| Champions Oncology, Inc. | -5.05 Million USD | -9698.397% |
| REGENXBIO Inc. | -239.46 Million USD | -106.8% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | -4520.287% |
| Anavex Life Sciences Corp. | -55.75 Million USD | -788.175% |
| Cellectar Biosciences, Inc. | -38.76 Million USD | -1177.362% |
| Edgewise Therapeutics, Inc. | -112.8 Million USD | -338.993% |
| Vaxart, Inc. | -74.72 Million USD | -562.729% |
| PharmaCyte Biotech, Inc. | - USD | Infinity% |
| Aldeyra Therapeutics, Inc. | -35.2 Million USD | -1306.518% |
| Cellectis S.A. | -98.09 Million USD | -404.828% |
| Longeveron Inc. | -20.06 Million USD | -2368.649% |
| Repare Therapeutics Inc. | -114.27 Million USD | -333.358% |
| Sarepta Therapeutics, Inc. | -439.19 Million USD | -12.754% |
| Inozyme Pharma, Inc. | -74.81 Million USD | -561.941% |
| Revolution Medicines, Inc. | -430.58 Million USD | -15.01% |
| Nymox Pharmaceutical Corporation | -6.28 Million USD | -7774.241% |
| Third Harmonic Bio, Inc. | -30.78 Million USD | -1508.402% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | -563.911% |
| AN2 Therapeutics, Inc. | 4.9 Million USD | 10200.163% |
| Anixa Biosciences, Inc. | -10.96 Million USD | -4416.288% |
| Vertex Pharmaceuticals Incorporated | 4.6 Billion USD | 110.753% |
| Denali Therapeutics Inc. | -179.97 Million USD | -175.158% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | -520035.913% |
| Veru Inc. | -89.97 Million USD | -450.384% |
| Corvus Pharmaceuticals, Inc. | -26.87 Million USD | -1742.44% |
| Cingulate Inc. | -22.95 Million USD | -2057.591% |
| Passage Bio, Inc. | -98.34 Million USD | -403.565% |
| Context Therapeutics Inc. | -25.06 Million USD | -1876.056% |
| Exicure, Inc. | -15.53 Million USD | -3086.891% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | -140.319% |
| Oramed Pharmaceuticals Inc. | -36.97 Million USD | -1239.277% |
| Scinai Immunotherapeutics Ltd. | -5.96 Million USD | -8205.292% |
| Rhythm Pharmaceuticals, Inc. | -168.46 Million USD | -193.957% |
| Nuvalent, Inc. | -149.49 Million USD | -231.263% |
| ABVC BioPharma, Inc. | -8.13 Million USD | -5989.347% |
| Carisma Therapeutics, Inc. | -85.89 Million USD | -476.537% |
| Unicycive Therapeutics, Inc. | -30.17 Million USD | -1540.967% |
| OmniAb, Inc. | -49.73 Million USD | -895.779% |
| Anew Medical, Inc. | -1.3 Million USD | -37968.556% |
| Fennec Pharmaceuticals Inc. | -12.36 Million USD | -3905.265% |
| Lipocine Inc. | -16.32 Million USD | -2933.886% |
| Lexeo Therapeutics, Inc. Common Stock | -66.67 Million USD | -642.779% |
| Nautilus Biotechnology, Inc. | -74.3 Million USD | -566.475% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | -1198.634% |
| G1 Therapeutics, Inc. | -39.01 Million USD | -1169.316% |
| Bellerophon Therapeutics, Inc. | -22.18 Million USD | -2132.39% |
| Sage Therapeutics, Inc. | -545.07 Million USD | 9.147% |
| Ocugen, Inc. | -64.82 Million USD | -663.896% |
| Mind Medicine (MindMed) Inc. | -92.57 Million USD | -434.958% |
| Q32 Bio Inc. | -86.5 Million USD | -472.485% |
| Brainstorm Cell Therapeutics Inc. | -16.92 Million USD | -2825.569% |
| Alumis Inc. Common Stock | -156.89 Million USD | -215.642% |
| Equillium, Inc. | -12.13 Million USD | -3979.84% |
| Kyverna Therapeutics, Inc. | -58.47 Million USD | -746.92% |
| Coya Therapeutics, Inc. | -7.9 Million USD | -6165.837% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | -2525.586% |
| Galera Therapeutics, Inc. | -46.69 Million USD | -960.591% |
| Evelo Biosciences, Inc. | -106.34 Million USD | -365.665% |
| Comera Life Sciences Holdings, Inc. | -17.88 Million USD | -2668.616% |
| Dominari Holdings Inc. | -22.44 Million USD | -2106.823% |
| Edesa Biotech, Inc. | -8.19 Million USD | -5946.428% |
| vTv Therapeutics Inc. | -25.41 Million USD | -1848.729% |
| Bio-Techne Corporation | 326.66 Million USD | 251.597% |
| Agios Pharmaceuticals, Inc. | -384.86 Million USD | -28.672% |
| Harmony Biosciences Holdings, Inc. | 216.38 Million USD | 328.852% |
| Prelude Therapeutics Incorporated | -131.1 Million USD | -277.712% |
| Candel Therapeutics, Inc. | -37.43 Million USD | -1222.997% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | -227.735% |
| Nkarta, Inc. | -120.48 Million USD | -311.028% |
| BioCardia, Inc. | -11.56 Million USD | -4183.832% |
| Iterum Therapeutics plc | -34.58 Million USD | -1332.073% |